Dr Walley is Associate Professor of Medicine and an addiction expert at Boston Medical Center and Boston University School of Medicine. Dr Walley has conducted multiple studies related to the opioid crisis and the integration of addiction specialty care and general medical care. He has served as PI on a CDC-SAMHSA-Epi-AID investigation of the surge in fentanyl-related overdose, a CDC-funded study of the Massachusetts OEND program which demonstrated community-level reductions in overdose death rates, and a SAMHSA-funded program that integrated addiction treatment into the clinical care of people with/at risk for HIV. He has worked as Co-I with addiction, overdose, and HIV expertise on NIDA and NIAAA-funded clinical trials and cohort studies.
Dr Walley is the director of the Boston Medical Center Addiction Medicine Fellowship program, as well as the director the NIDA-funded Fellow Immersion Training program in Addiction Medicine, which trains 5 subspecialty fellows each year to integrate addiction science into their subspecialty research. He provides primary care and addiction medicine consultations in the HIV primary care clinic at Boston University School of Medicine/BMC where he leads the FAST PATH (Facilitated Access to Substance abuse Treatment for Prevention and Treatment of HIV) program. Dr Walley co-founded and provides care on the inpatient addiction consult service at Boston Medical Center, which regularly provides consultation for patients admitted to the hospital who use alcohol and substances. Lastly, Dr Walley has been the medical director of the Massachusetts Opioid Overdose Prevention program since it started in 2007. They have trained and equipped over 80,000 people in the community with naloxone rescue kits, culminating in over 19,000 documented overdose rescues.
- Courtesy Staff Privileges, Medicine, Boston Medical Center
- Johns Hopkins University School of Medicine, MD
- Boston University School of Public Health, MSc
- Harvard College, AB
- Published on 12/20/2019
Burstein D, Baird J, Bratberg J, Donovan E, Soipe A, Tapper A, Case P, Walley AY, Green TC. Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study. J Am Pharm Assoc (2003). 2019 Dec 20. PMID: 31870862.
- Published on 11/15/2019
Green TC, Bratberg J, Baird J, Burstein D, Lenz K, Case P, Walley AY, Xuan Z. Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy. Int J Drug Policy. 2019 Nov 15; 102602. PMID: 31740174.
- Published on 11/5/2019
Thakarar K, Walley AY, Heeren TC, Winter MR, Ventura AS, Sullivan M, Drainoni M, Saitz R. Medication for addiction treatment and acute care utilization in HIV-positive adults with substance use disorders. AIDS Care. 2019 Nov 05; 1-5. PMID: 31686528.
- Published on 10/23/2019
Taylor JL, Walley AY, Bazzi AR. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Subst Abus. 2019; 40(4):441-443. PMID: 31644387.
- Published on 10/10/2019
Kimmel SD, Walley AY, Linas BP, Kalesan B, Awtry E, Dobrilovic N, White L, LaRochelle M. Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis. Clin Infect Dis. 2019 Oct 10. PMID: 31598642.
- Published on 10/4/2019
Bagley SM, Larochelle MR, Xuan Z, Wang N, Patel A, Bernson D, Silverstein M, Hadland SE, Land T, Samet JH, Walley AY. Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose. Ann Emerg Med. 2020 Jan; 75(1):29-38. PMID: 31591014.
- Published on 10/2/2019
Walley AY, Bernson D, Larochelle MR, Green TC, Young L, Land T. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015. Public Health Rep. 2019 Nov/Dec; 134(6):667-674. PMID: 31577519.
- Published on 10/1/2019
Merlin JS, Samet JH, Cheng DM, Lira MC, Tsui JI, Forman LS, Colasanti J, Walley AY, Del Rio C, Liebschutz JM. Marijuana Use and Its Associations With Pain, Opioid Dose, and HIV Viral Suppression Among Persons Living With HIV on Chronic Opioid Therapy. J Acquir Immune Defic Syndr. 2019 Oct 01; 82(2):195-201. PMID: 31513554.
- Published on 9/30/2019
Kurian S, Baloy B, Baird J, Burstein D, Xuan Z, Bratberg J, Tapper A, Walley A, Green TC. Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians. J Am Pharm Assoc (2003). 2019 Nov - Dec; 59(6):824-831. PMID: 31582224.
- Published on 9/3/2019
Larochelle MR, Bernstein R, Bernson D, Land T, Stopka TJ, Rose AJ, Bharel M, Liebschutz JM, Walley AY. Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study. Drug Alcohol Depend. 2019 Nov 01; 204:107537. PMID: 31521956.
View 106 more publications: View full profile at BUMC